Regulation of retrotransposable element activity in Drosophila.
Regulation of retrotransposable element activity in Drosophila.
批准号:
9150884
负责人:
STEPHEN L HELFAND
金额:
$40.75万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-09-01 至 2021-05-31
关键词:
AffectAgeAgingAging-Related ProcessBiological ModelsBrainChromatinCollaborationsDNA DamageDNA Double Strand BreakDNA SequenceDrosophila genusElementsEnzymesFat BodyFunctional disorderGenesGeneticGenetic ScreeningGenomeGenomic InstabilityGenomicsGoalsHIVHeterochromatinHigh-Throughput DNA SequencingHigh-Throughput RNA SequencingHomeostasisHumanIndiumInterventionLeadLongevityMaintenanceMeasuresMethodsMethyltransferaseModelingMolecularMolecular GeneticsMonitorMusNucleosidesOrganismPathway interactionsPharmaceutical PreparationsRNA EditingRNA InterferenceRegulationReporterRepressionRetrotranspositionRetrotransposonReverse Transcriptase InhibitorsRoleSirtuinsSmall RNASomatic CellTestingTimedietary restrictionflygene therapygenetic manipulationheterochromatin-specific nonhistone chromosomal protein HP-1knock-downnormal agingtool
中文摘要
项目总结(项目2)
本项目的重点是利用果蝇模型系统来研究逆转座子的作用
在衰老过程中发生的细胞功能障碍的进展中的元素(RTE),并发展成
抑制RTE活动和延长健康寿命的发明。保持压抑性的异质-
染色质随着年龄的增长而下降,导致rtes在物种间的表达和动员增加,如
种类繁多,如果蝇和老鼠。我们假设RTES的表达和动员的增加
导致体细胞基因组损伤的累积,导致细胞和有机体的损失
动态平衡,从而促进衰老。我们将使用强大的分子和基因工具以及短暂的生命
以确定RTES对衰老的影响,特别是我们将在整个
生物体的寿命,这在人类是不可能的,而且是令人望而却步的时间-
在任何哺乳动物模型系统中大规模消耗和昂贵。一种机械论的确认
RTE活动与衰老之间的关系将为制定干预措施奠定基础
减少衰老过程中的RTE活性和基因组损伤,并应延长健康寿命。
这项提议的目的是检验以下假设:(I)染色质调节的抑制的丧失
RTE活性随年龄增长与DNA损伤增加和基因组不稳定有关;(Ii)
随着年龄的增长,sirtuin导致RTE活性升高,这可以通过增加sirtuin活性来逆转;以及(Iii)
抑制体细胞中RTE活性的干预措施可以延长健康寿命。
为了更好地了解RTE活性、基因组损伤和寿命之间的关系,以及
开发能够延长健康寿命的新干预措施,在目标1中,我们将开发高通量DNA
排序方法(与项目1合作,核心B),部署可用的和新的RTE记者
(与核心B合作)测量老年果蝇的RTE动员,并开展一项
基因筛查以确定参与抑制RTES的新基因和途径。我们将研究
(I)年龄、(Ii)饮食限制(DR)和(Iii)稳定异染色质的遗传干预的影响,如
随着SU(Var)3-9、HP1a、DICER-2、Piwi表达的增加或Adar表达的减少,对RTE活性和动员的影响。
在目标2中,为了确定Sir2和SIRT6在衰老过程中抑制RTE活性的作用,我们将结合
在目标1中开发和使用的工具,通过增加或
减少Sir2和SIRT6活动的表达(与项目3和核心B合作)。在《目标3》中,我们将
(1)确定目标1和目标2中制定的遗传干预措施对苍蝇寿命的影响
(与项目1和3以及核心B合作),以及(Ii)测试核苷逆转录酶的效果
特异性反转录转座子的抑制物(NRTI)和RNAi敲除对RTE动员和寿命的影响
(与项目1和3以及核心B合作)。
英文摘要
PROJECT SUMMARY (PROJECT 2)
The focus of this project is to exploit the Drosophila model system to study the role of retrotransposable
elements (RTEs) in the progression of cellular dysfunction that occurs during aging, and to develop inter-
ventions that suppress RTE activity and extend healthy life span. The maintenance of repressive hetero-
chromatin declines with age, resulting in increased expression and mobilization of RTEs across species as
diverse as fruitflies and mice. We hypothesize that the increase in the expression and mobilization of RTEs
leads to an accumulation of damage to the genome of somatic cells, causing loss of cellular and organismal
homeostasis, and thus promoting aging. We will use the powerful molecular and genetic tools and the short life
span of Drosophila to determine the effects of RTEs on aging, and in particular, we will do this over the entire
life span of the organism, something that would not be possible in humans, and would be prohibitively time-
consuming and expensive in any mammalian model system on a large scale. Confirmation of a mechanistic
relationship between RTE activity and aging will provide the groundwork for developing interventions that
diminish RTE activity and genomic damage during aging, and should extend healthy life span.
The aims of this proposal are to test the hypotheses that: (i) loss of chromatin-regulated suppression of
RTE activity with age is associated with increased DNA damage and genome instability; (ii) decreases in
sirtuins with age lead to elevated RTE activity that can be reversed by increasing sirtuin activity; and (iii)
interventions that suppress RTE activity in somatic cells can extend healthy life span.
To better understand the relationship between RTE activity, genomic damage and longevity, as well as to
develop new interventions that can extend healthy life span, in Aim 1 we will develop high throughput DNA
sequencing methods (collaboration with Project 1, Core B), deploy available and new RTE reporters
(collaboration with Core B) to measure mobilization of RTEs in aging Drosophila, and carry out a forward
genetic screens to identify new genes and pathways involved in the suppression of RTEs. We will examine the
effects of (i) age, (ii) dietary restriction (DR), and (iii) genetic interventions that stabilize heterochromatin, such
as increasing Su(var)3-9, HP1a, Dicer-2, Piwi or decreasing Adar expression, on RTE activity and mobilization.
In Aim 2, to determine the role of Sir2 and Sirt6 in the repression of RTE activity during aging, we will combine
the tools developed and utilized in Aim 1 to monitor RTE activity with genetic manipulations that increase or
decrease the expression of Sir2 and of Sirt6 activity (collaboration with Project 3 and Core B). In Aim 3, we will
(i) determine the effects of the genetic interventions developed in Aims 1 and 2 on the life span of flies
(collaboration with Projects 1 and 3 and Core B), and (ii) test the effects of nucleoside reverse transcriptase
inhibitors (nRTIs) and RNAi knockdowns of specific retrotransposons on RTE mobilization and lifespan
(collaboration with Projects 1 and 3 and Core B).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Genetic and Functional Mechanisms in Citrate Transporter Disorder associated with SLC13A5
-
批准号:10651203
-
项目类别:
-
资助金额:$65.22万
-
财政年份:2023
-
负责人:STEPHEN L HELFAND
-
依托单位:
Hierarchy and intersection of hallmarks of aging using genetic, pharmacologic, and dietary life span extending interventions in flies and mice.
-
批准号:10901046
-
项目类别:
-
资助金额:$39.58万
-
财政年份:2023
-
负责人:STEPHEN L HELFAND
-
依托单位:
The effect of life span modifying interventions on Alzheimer's Disease in Drosophila and Mice.
-
批准号:10609394
-
项目类别:
-
资助金额:$58.96万
-
财政年份:2020
-
负责人:STEPHEN L HELFAND
-
依托单位:
The effect of life span modifying interventions on Alzheimer's Disease in Drosophila and Mice.
-
批准号:10375432
-
项目类别:
-
资助金额:$58.96万
-
财政年份:2020
-
负责人:STEPHEN L HELFAND
-
依托单位:
Project 2: Role of Retrotransposable Element Activity in Drosophila Models of Alzheimer's Disease
-
批准号:10581529
-
项目类别:
-
资助金额:$57.05万
-
财政年份:2016
-
负责人:STEPHEN L HELFAND
-
依托单位:
Project 2: Role of Retrotransposable Element Activity in Drosophila Models of Alzheimer's Disease
-
批准号:10333662
-
项目类别:
-
资助金额:$57.97万
-
财政年份:2016
-
负责人:STEPHEN L HELFAND
-
依托单位:
Single Gene Mutants that Confer Longevity in Drosphila
-
批准号:7919036
-
项目类别:
-
资助金额:$12.52万
-
财政年份:2009
-
负责人:STEPHEN L HELFAND
-
依托单位:
Oxidative Damage, Aging and Life Span
-
批准号:6987986
-
项目类别:
-
资助金额:$30.61万
-
财政年份:2005
-
负责人:STEPHEN L HELFAND
-
依托单位:
Oxidative Damage, Aging and Life Span
-
批准号:7253938
-
项目类别:
-
资助金额:$29.74万
-
财政年份:2005
-
负责人:STEPHEN L HELFAND
-
依托单位:
Oxidative Damage, Aging and Life Span
-
批准号:7640938
-
项目类别:
-
资助金额:$29.12万
-
财政年份:2005
-
负责人:STEPHEN L HELFAND
-
依托单位:
Oxidative Damage, Aging and Life Span
-
批准号:7123784
-
项目类别:
-
资助金额:$30.35万
-
财政年份:2005
-
负责人:STEPHEN L HELFAND
-
依托单位:
Oxidative Damage, Aging and Life Span
-
批准号:7455844
-
项目类别:
-
资助金额:$29.13万
-
财政年份:2005
-
负责人:STEPHEN L HELFAND
-
依托单位:
Control of Gene Expression and Life Span
-
批准号:7472418
-
项目类别:
-
资助金额:$34.96万
-
财政年份:2004
-
负责人:STEPHEN L HELFAND
-
依托单位:
Control of Gene Expression and Life Span
-
批准号:6951396
-
项目类别:
-
资助金额:$33.65万
-
财政年份:2004
-
负责人:STEPHEN L HELFAND
-
依托单位:
Control of Gene Expression and Life Span
-
批准号:8113179
-
项目类别:
-
资助金额:$31.6万
-
财政年份:2004
-
负责人:STEPHEN L HELFAND
-
依托单位:
Control of Gene Expression and Life Span
-
批准号:7271307
-
项目类别:
-
资助金额:$34.64万
-
财政年份:2004
-
负责人:STEPHEN L HELFAND
-
依托单位:
Control of Gene Expression and Life Span
-
批准号:6818132
-
项目类别:
-
资助金额:$32.14万
-
财政年份:2004
-
负责人:STEPHEN L HELFAND
-
依托单位:
Control of Gene Expression and Life Span
-
批准号:9267122
-
项目类别:
-
资助金额:$33.31万
-
财政年份:2004
-
负责人:STEPHEN L HELFAND
-
依托单位:
Control of Gene Expression and Life Span
-
批准号:7891392
-
项目类别:
-
资助金额:$32.88万
-
财政年份:2004
-
负责人:STEPHEN L HELFAND
-
依托单位:
Control of Gene Expression and Life Span
-
批准号:8305531
-
项目类别:
-
资助金额:$31.6万
-
财政年份:2004
-
负责人:STEPHEN L HELFAND
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: